(IN BRIEF) Look Good Feel Better, in partnership with England Netball, organized its Annual Charity Netball Tournament at the University…
(IN BRIEF) Fresenius Kabi announces FDA approval of Tyenne® (tocilizumab-aazg), the first tocilizumab biosimilar offering both IV and subcutaneous formulations.…
(IN BRIEF) Dr. Kenneth Rankin, an honorary senior lecturer at Newcastle University, was bestowed with the prestigious Researcher of the…
(IN BRIEF) Researchers in Finland have conducted a study to understand why some chronic myeloid leukaemia (CML) patients can safely…
(IN BRIEF) Merck, a prominent science and technology company, has entered into a strategic partnership with Jiangsu Hengrui Pharmaceuticals. This…
(IN BRIEF) Novartis has announced successful results from its Phase III NETTER-2 trial involving Lutathera, a treatment for neuroendocrine tumors…
(IN BRIEF) A new spin-out drug discovery company from the University of Liverpool called Sulantrix is exploring new cancer medicines…
(ACTUALITÉ EN BREF) Une nouvelle société dérivée de découverte de médicaments de l'Université de Liverpool appelée Sulantrix explore de nouveaux…
(PRESS RELEASE) BRISTOL, 19-Apr-2022 — /EuropaWire/ — University of Bristol, a red brick research university, has announced that it is…
(COMMUNIQUÉ DE PRESSE) BRISTOL, 19-Apr-2022 — /EuropaWire/ — University of Bristol, a red brick research university, has announced that it…
Author looking for a sponsor (PRESS RELEASE) JELGAVA, Latvia, 29-Mar-2022 — /EuropaWire/ — Still Alive was begun by Andrej Statskij…
(PRESS RELEASE) CAMBRIDGE, 24-Sep-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical and biopharmaceutical company, has announced positive…
Why identical mutations cause different types of cancer Cancer development is influenced by tissue type (PRESS RELEASE) MUNICH, 20-Jul-2021 —…
(PRESS RELEASE) FREIBURG, Germany, 1-Jul-2021 — /EuropaWire/ — Prostate cancer is the second most common cancer. According to the American…
Accelerating projects on access to medicines, support for vulnerable communities, environmental conservation, and diversity and inclusion Creation of Sanofi Global Health, global…
(PRESS RELEASE) Sophia Antipolis Cedex, France, 29-Mar-2021 — /EuropaWire/ — European Society of Cardiology (ESC) announces that its online scientific…
(PRESS RELEASE) LONDON, 15-Feb-2021 — /EuropaWire/ — British multinational insurance company Aviva to help its protection customers living with cancer…
Plans in place to become a top 10 global contributor (PRESS RELEASE) BERKSHIRE, 11-Sep-2020 — /EuropaWire/ — British multinational telecommunications…
uPath PD-L1 (SP263) image analysis uses automated pre-computing and one-click scoring to enable quicker and accurate detection and measurement of…
(PRESS RELEASE) THE HAGUE, 19-Jun-2020 — /EuropaWire/ — The Dutch Research Council (NWO) has announced that six researchers will receive…
Tecentriq in combination with Avastin is the first and only cancer immunotherapy regimen approved for the treatment of unresectable or…
The new immunotherapy will be tested in humans as soon as possible (PRESS RELEASE) ZURICH, 8-May-2020 — /EuropaWire/ — University…
The first Rhenium-SCT® treatment was accomplished by the interregional professional association for nuclear medicine in Hanau (PRESS RELEASE) HANAU, Germany,…
New recognition of OncoBeta’s success in developing and providing an innovative therapy for non-melanoma skin cancer patients. (PRESS RELEASE) Pasadena,…
The interregional professional association for nuclear medicine in Hanau is the first treatment center in Germany offering Rhenium-SCT® for the…
https://www.youtube.com/watch?v=RylXHwSa_kc University of Pretoria Prof. Mike Sathekge is First in South Africa to Treat Non-Melanocytic Skin Cancer Patients with Rhenium-SCT®…
EXETER, 05-Oct-2018 — /EuropaWire/ — An Exeter paper has won Research Paper of the Year under the cancer category in the…
SOLAR-1 evaluated BYL719 plus fulvestrant vs. fulvestrant alone in HR+/HER2- advanced breast cancer patients with PIK3CA mutations who progressed on…
Lynparza met primary endpoint of progression-free survival in women with BRCA-mutated advanced ovarian cancer and showed a safety profile consistent…
Researchers at KTH and Karolinska Institutet have concluded that AI can contribute to increased understanding of how prostate cancer develops,…
University of Birmingham researchers are leading the way with a ground-breaking role to enable more children with the rare cancer…
DUNDEE, Scotland, 11-Jun-2018 — /EuropaWire/ — Professor Bob Steele, of the University of Dundee, has been awarded a CBE in HM…
First phase of Singapore’s Advanced Medicine Imaging Center provides accurate and timely diagnosis of cancer, plus an education center for…
With millimetre precision, certain tumours can be irradiated at the Paul Scherrer Institute PSI using protons – that is, positively…
LEEDS, 03-May-2018 — /EuropaWire/ — New drugs in the early stages of development by pharmaceutical companies could have an extra…
COVENTRY, 02-May-2018 — /EuropaWire/ — Improved care for patients undergoing cancer surgery is the focus of a pioneering worldwide study.…
https://youtu.be/782tw7_MwH0 MANAMA, Bahrain, 21-Apr-2018 — /EuropaWire/ — In a statement from his children they said: "It is with great sorrow…
STOCKHOLM, 18-Apr-2018 — /EuropaWire/ — One way that cancer may be fought in the future is with micro-sized capsules containing living…
SWINDON, 12-Apr-2018 — /EuropaWire/ — STFC and EPSRC have launched a joint funding call with Cancer Research UK that aims to…
SOUTHAMPTON, 02-Apr-2018 — /EuropaWire/ — Many patients receiving chemotherapy following surgery for bowel cancer may only need three months treatment rather…